BackMycenax Biotech Overview

Mycenax Biotech Current Cash

Track Mycenax Biotech's current cash ($260M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$263.74M
↑ 24.44% YoYΔ $51.79M vs prior year quarter

Peer trimmed avg / median

Loading

Mycenax Biotech Current Cash History

Loading

Mycenax Biotech vs. peers: Current Cash Comparison

Loading

Mycenax Biotech Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Mycenax Biotech (4726.TWO) FAQ

Mycenax Biotech (4726.TWO) currently reports a current cash of $260M as of June 2026. That compares with $210M in the prior-year period — up 24.4% year over year. Use the charts on this page to explore Mycenax Biotech's current cash history and peer comparisons.

Mycenax Biotech's current cash increased from $210M to $260M — a 24.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Mycenax Biotech reported $260M in current cash as of June 2026. That compares with $210M in the prior-year period — up 24.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $260M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Mycenax Biotech, and consider following 4726.TWO for alerts when major investors trade the stock.

Mycenax Biotech is classified in the Healthcare sector. On current cash, it currently shows $260M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4726.TWO with unrelated industries.